A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/16 (2006.01) A61K 31/35 (2006.01) A61P 31/00 (2006.01) C12P 17/16 (2006.01) C12Q 1/18 (2006.01)
Patent
CA 2760159
The present invention is directed to methods of treating a bacterial infection in a subject through the administration of a therapeutically effective amount of a glycopeptide antibiotic to a subject having a bacterial infection. The effective amount of the glycopeptide antibiotic that is administered to the subject provides a fraction of the glycopeptide antibiotic administered to the subject bound to serum proteins within the subject and within a selected range.
La présente invention porte sur des procédés de traitement d'une infection bactérienne chez un sujet par l'administration d'une quantité thérapeutiquement efficace d'un antibiotique glycopeptidique à un sujet atteint d'une infection bactérienne. La quantité efficace de l'antibiotique glycopeptidique qui est administré au sujet fournit une fraction de l'antibiotique glycopeptidique administré au sujet lié aux protéines du sérum à l'intérieur du sujet et à l'intérieur d'une plage choisie.
Beaulieu Sylvain
Lehoux Dario
Mckay Geoffrey
Moeck Gregory
Parr Thomas Jr.
Gowling Lafleur Henderson Llp
Targanta Therapeutics Corp.
LandOfFree
Methods of treating bacterial infections using oritavancin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating bacterial infections using oritavancin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating bacterial infections using oritavancin will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1603689